6 days ago3 minProteona leads international consortium to develop SARS-CoV-2 neutralizing antibodyInnovative AI-driven proteogenomic analysis company applies single cell analysis expertise to developing treatments for COVID-19 to help vulnerable immunocom...
Mar 234 minOne more step towards true precision medicineProteona, Synovo, and NMI announced collaboration on a single cell multi-omics profiling platform for patient-derived micro-tumors Singapore, 23 March 2020 -...
Mar 122 min€2.45 m to investigate leukaemia causes and therapiesThe Heidelberg-based LeukoSyStem consortium investigates leukaemia stem cells in acute myeloid leukaemia. The German Federal Ministry of Education and Rese...
Feb 201 minArtificial pericardial tissue from the 3D printerTogether with its project partners, the NMI can already report initial successes in the PolyKARD project, specifically the synthesis and printing of elastic ...
Jan 141 minBioMed X starts new schizophrenia research program with Boehringer IngelheimHeidelberg, Germany, January 13th, 2020 – BioMed X announced today the start of a new joint research group in collaboration with Boehringer Ingelheim at th...
Jan 102 minBausch Health licenses Novaliq’s NOV03 investigational treatment for dry eye disease Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health”) and Bausch + Lomb, its leading global eye health business, and Novaliq GmbH, a pharmaceutical ...
Jan 101 minBioMed X starts new research program in autoimmune diseases with MerckHeidelberg, Germany, January 9th, 2020 – BioMed X announced today the start of a new joint research group in collaboration with Merck. With this new group,...
Jan 82 minVelabs Therapeutics and alytas enter into a licence agreement for senescenceVelabs Therapeutics receives exclusive licence from alytas therapeutics for the development of therapeutic antibodies as senolytics Heidelberg and Jena, Germ...
Jan 72 minNeuro-Sys and Sciomics announce Partnership AgreementNeuro-Sys and Sciomics announce a collaboration to co-develop an unrivaled integrated preclinical solution in neurodegenerative disorders. GARDANNE, France a...
Dec 5, 20192 minEMBL and Leica sign open innovation agreementLeica Microsystems and EMBL have signed a unique long-term framework collaboration agreement to provide new imaging technologies. The agreement is the firs...
Sep 24, 20192 minBioMed X successfully completes collaboration on development of nanomaterial-based biosensorsHeidelberg, Germany, September 23, 2019 – BioMed X announced today the completion of their first research collaboration project with Roche Diagnostics in t...
Sep 20, 20192 minHeidelberg Pharma receives European Union research grant for the ETN MAGICBULLET project Ladenburg, 19 September 2019 – Heidelberg Pharma AG (FSE : WL6) today announced that its subsidiary Heidelberg Pharma Research GmbH will receive a research...
Sep 12, 20192 minPROGEN secures exclusive rights for AAV products from the German Cancer Research Center (DKFZ)Extensive licenses for research antibodies and test systems strengthen position in the gene therapy market. Heidelberg, 12.09.2019 – PROGEN Biotechnik GmbH, ...
Jul 31, 20191 minYUMAB announces new research & collaboration agreement with MerckYUMAB GmbH, a privately-held German biotechnology company, and Merck, a leading science and technology company, have signed a research and collaborati...
Apr 11, 20191 minPhenex collaborates with Mathias Heikenwaelder ́s research group from DKFZThe biotech company and Prof. Dr. Heikenwälder see common ground for joint research projects in NASH and cancer metabolism Phenex Pharmaceuticals AG (Phenex...
